אימנד 150 מ"ג IV

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Dostupné s:

MERCK SHARP & DOHME ISRAEL LTD

ATC kód:

A04AD12

Léková forma:

POWDER FOR SOLUTION FOR INFUSION

Podání:

I.V

Výrobce:

MERCK SHARP & DOHME B.V, HOLLAND

Terapeutické skupiny:

APREPITANT

Terapeutické indikace:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Datum autorizace:

2011-11-01